Can we help you find something?

Can we help you find something?

Clinical Trials

Clinical trials offer patients the very latest in cancer care while giving physicians and researchers the opportunity to study the effectiveness of the treatment. The Capital Health Cancer Center participates in many National Cancer Institute, University and Pharmaceutical Phase III clinical trials. Our oncologists and research nurses carefully review the study criteria, potential benefits, risks, and other considerations with eligible patients before enrolling in a clinical study. The staff in our Clinical Research Department will carefully monitor you throughout the clinical trial and answer any questions you may have about the trial.

Please contact Tina Bergner, RN, BSN, OCN, oncology clinical research coordinator, at 609-537-7042 or e-mail her at [email protected] for more information.

Active clinical trials currently being offered:

Brain studies

NRG-BN001: Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy vs. Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma

A071102:  A Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed GBM with MGMT Promoter Hypermethylation (currently on sponsor initiated interim hold since 10/2016)

Breast studies

A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) who Have positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

NSABP B-51/RTOG 1304: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

A011104:  Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

NRG BR-003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plust Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High Risk Node-Negative Triple-Negative Invasive Breast Cancer

MATCH studies

EAY131: Molecular Analysis for Therapy Choice (MATCH) – Patients enrolled in study will have a tumor biopsy for molecular characterization and those with molecular variants addressed by treatments included in the trial will be offered treatment. Patients with histologically documented solid tumors and lymphomas whose disease has progressed following at least one line of standard systemic therapy or for whom no standard therapy exists will be registered on the screening step to undergo tumor biopsy and analysis.

Pancreas studies

A021501: Preoperative Extended Chemotherapy vs. Chemotherapy plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas (pending WIRB review, CH IRB approved)

Spine studies

RTOG 0631: Phase II/III study of image-guided radiosurgery/SBRT for localized spine metastasis

Others
  • Post-Mastectomy ROM Study - (Dr. Lisa Allen) – Comparison of Upper Extremity Range of Motion in Post-Mastectomy Patients with and without formal mobility exercise education and initiation at time of mastectomy
  • Radiation Oncology Studies - Establishing an anticipatory model for anxiety and depression through a screening tool for first-time radiation oncology patients
  • Rutgers Cancer Institute of New Jersey – African American Woman’s Circle of Health Breast Cancer Research Study
  • Dana-Faber/Brigham and Woman’s Cancer Center (Dr. Geoffrey Oxnard) – INHERIT EGFR (Genetic Mutation T790M Lung Registry Study)

Other resources:

New Specialists Join Capital Health’s Stroke & Cerebrovascular Center

With a reputation for providing advanced care to patients with complex, neurological conditions affecting the brain and spine, Capital Institute for Neurosciences recently welcomed two new advanced specialists, Drs. Vernard Fennell and Varun Naragum, to the Institute’s Stroke and Cerebrovascular Center team. They join neurosurgeon Dr. Michael F. Stiefel in providing some of the latest techniques to care for stroke patients.

Advanced Testing and Surgery for Pancreatic Cancer Available at Capital Health

Pancreatic cancer is the fourth leading cause of cancer-related deaths in the US, with more than 48,000 new cases diagnosed each year. Because pancreas cancers and precancerous lesions are among the most challenging tumors to diagnose and effectively treat, Capital Health now offers the most advanced screening and treatment options as part of its Center for Digestive Health and Cancer Center, both located at Capital Health Medical Center – Hopewell.

Helping Chronic Wounds Heal Faster

For those with diabetes or poor circulation, an injury or wound to the legs and feet can be slow to heal.

For almost 30 years, residents in Mercer and adjacent counties have relied on Capital Health’s certified wound care team of physicians and nurses to provide comprehensive health care for patients with chronic wounds and hyperbaric oxygen therapy for those with qualifying conditions.

View All News
View All Events